Skip to main content

CCTG Connection



Published:
Category: Group updates
#CCTG2023 Spring Meeting is almost here

Request an invitation portal: closes April 17th

Online Registration: closes April 19th

  • Pre-registering online will ensure a faster on-site registration process as your name tag will be ready for pick-up.

On-site Registration: Beat the Friday morning line-up and register on Thursday!!

Read More

Published:
Category: Group updates
CCTG Recruiting for a Patient Representative Volunteer Role
Role Description The Canadian Cancer Trials Group (CCTG) is currently seeking applications for a Patient Representative for the Gastro-Intestinal Disease Site Committee. CCTG is an inclusive organization dedicated to building a diverse network. We encourage applications from all qualified candidates and will accommodate applicants’ needs throughout all stages of the recruitment and selection process. Read More

Published:
Category: Group updates
CCTG Plenary Session
The CCTG Plenary Session will be held at the Annual Spring Meeting of Participants on Friday April 28, 2023 from 4:30 – 5:30 pm in the Mountbatten room at the Chelsea Hotel in Toronto. The session will feature discussion on four outstanding clinical trials, CX1 (SHAPE) IND227 Phase II results, ENC1 a Phase III study, and the HE1 Phase III study. Read More

Published:
Category: Group updates
At Spring Meeting #CCTG2023 the entertainment event you have been waiting for! Featuring some of our research musical friends: Old Docs New Tricks, The Remedies and Supper Club The event will be a fundraiser for the Canadian Cancer Society, and we will be accepting admission donations at the door. To attend you will need your CCTG Spring Meeting name badge. Read More

Published:
Category: News
A special congratulations to the next cohort for the 2023-2024 New Investigator Cancer Trials Practicum and on behalf of the entire CCTG network, we extend our congratulations to the 2022-2023 New Investigator Cancer Trials Practicum graduates. Read More

Published:
Category: News
 LUMOS2 international trial

Canadian Cancer Society announces details of research funding for low-survival cancers, the CCTG Breakthrough Grant Application lead by Dr Marshall Pitz, has received $ 1,549,130 over 5 years.

Read More

Published:
Category: Publications
Publication: CO17|CO20 statistical
Bayesian approach for two-stage multivariate Mendelian randomization with mixed outcomes
 
Deng Y, Tu D, O'Callaghan CJ, Jonker DJ, Karapetis CS, Shapiro J, Liu G, Xu W. A Bayesian approach for two-stage multivariate Mendelian randomization with mixed outcomes (ONLINE).
Read More

Published:
Category: Trials
Closed to Accrual: C029

The CO29 trial: Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage III Colon Cancer: A Multicentre Phase II/III Randomised Controlled Sutdy, AGITG DYNAMIC-III has closed to accrual. The study reached its overall accrual target of 1000 patients, 209 of which were randomized by Canadian sites.

Read More